Subretinal Injection of tPA Myopic Staphyloma

Show Description +

Frederic Aissani, MD, performs internal limiting membrane peel and subretinal injection of tissue plasminogen activator (tPA) in the single eye of a 75-year-old woman with myopic staphyloma who experienced a sudden loss of vision.

Posted: 11/23/2022

Subretinal Injection of tPA Myopic Staphyloma

Frederic Aissani, MD, performs internal limiting membrane peel and subretinal injection of tissue plasminogen activator (tPA) in the single eye of a 75-year-old woman with myopic staphyloma who experienced a sudden loss of vision.

Posted: 11/23/2022

Please log in to leave a comment.

More in Retina

The Way You Think Matters

Tarek S. Hassan, MD, interviewed by Timothy G. Murray, MD, MBA

Three Tips to Improve Retina Surgery

David R. Chow, MD, interviewed by Timothy G. Murray, MD, MBA

A Look at Optogenetics

Allen C. Ho, MD, interviewed by Timothy G. Murray, MD, MBA

Implementing AI in Retina

Robert L. Avery, MD, interviewed by R.V. Paul Chan, MD, MSc, MBA